Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
California Stem Cell Treatment Center is a clinical organization specializing in the isolation and application of autologous adipose-derived stem cells. Founded by Dr. Mark Berman and Dr. Elliot Lander, the center utilizes a point-of-care surgical process to extract stromal vascular fraction (SVF) from a patient's own fat tissue for the treatment of various degenerative and inflammatory conditions. The organization also established the Cell Surgical Network, an international affiliation of physicians who utilize their standardized protocols for regenerative medicine. The company's operations have been central to landmark legal challenges regarding the FDA's authority to regulate autologous cell therapies as drugs. Their services target a wide range of therapeutic areas including orthopedics, neurology, and autoimmune disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on California Stem Cell Treatment Center.